scispace - formally typeset
G

Gireesh B. Reddy

Researcher at Duke University

Publications -  13
Citations -  554

Gireesh B. Reddy is an academic researcher from Duke University. The author has contributed to research in topics: Postoperative complication & In vivo. The author has an hindex of 5, co-authored 13 publications receiving 373 citations. Previous affiliations of Gireesh B. Reddy include Walter Reed Army Institute of Research & University of Miami.

Papers
More filters
Journal ArticleDOI

Titanium surface characteristics, including topography and wettability, alter macrophage activation

TL;DR: It is demonstrated that macrophages cultured on high surface wettability materials produce an anti-inflammatory microenvironment, and this property may be used to improve the healing response to biomaterials.
Journal ArticleDOI

Post-operative delirium is an independent predictor of 30-day hospital readmission after spine surgery in the elderly (≥65 years old): A study of 453 consecutive elderly spine surgery patients

TL;DR: Preventable measures and early awareness of post-operative delirium in the elderly may help reduce readmission rates and prevent unplanned readmission within 30-days of discharge.
Journal ArticleDOI

Impact of Gender Disparities on Short-Term and Long-Term Patient Reported Outcomes and Satisfaction Measures After Elective Lumbar Spine Surgery: A Single Institutional Study of 384 Patients.

TL;DR: It is suggested that there may be differences in perception of health, pain, and disability between men and women at baseline, short-term and long-term follow-up that may influence overall patient satisfaction.
Journal ArticleDOI

Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) shows efficacy against Osteosarcoma

TL;DR: Niclosamide was optimized for preclinical drug delivery as a unique prodrug nanoparticle injected intravenously at 50 mg/kg (1.9 mmol/L) to improve the low and inefficient clinical bioavailability of oral dosing, especially for the relatively hydrophobic classes of anticancer drugs.